For most physicians, difficult conversations come with the territory.
After the initial shock of hearing a serious diagnosis and absorbing what the prognosis could mean, the next question patients often ask is why. Why me? Why now?
For patients with advanced stage cancer, time is life.
HudsonAlpha Institute for Biotechnology has joined 13 of the nation's top cancer research centers in the Oncology Research Information Exchange Network® (ORIEN), a collaboration to accelerate clinical development and discovery of treatments for advanced-stage cancers.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: